Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Pancreatic Neoplasms 3Multiple Myeloma 3Unspecified Adult Solid Tumor, Protocol Specific 2Solid Tumor 2Neoplasms 2Melanoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Refractory or Relapsed Solid Tumors 1Recurrence 1Prostatic Neoplasms 1Neoplasms, Plasma Cell 1Malignant Solid Tumour 1Lymphangioleiomyomatosis 1Leukemia, Myeloid, Acute 1Leukemia 1Gastrointestinal Neoplasms 1Estrogen Receptor Positive Breast Cancer 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bone Metastases 1Adult Solid Neoplasm 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Hydroxychloroquine × Clear all
NCT02232243 2021-06-28

HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors

University of Kentucky

Phase 1 Completed
10 enrolled 9 charts
Tumor-Agnostic

Neoplasms

NCT01266057 2021-03-04

Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
143 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡